1342059
USP
Insulin glargine
United States Pharmacopeia (USP) Reference Standard
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
grade
pharmaceutical primary standard
API family
insulin
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
−20°C
Looking for similar products? Visit Product Comparison Guide
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
Insulin Glargine, a peptide produced by recombinant DNA techniques is composed of two chains - the A-chain (21 amino acids) and the B-chain (32 amino acids), making up a total of 53 amino acids. Its primary structure is almost identical to that of Human Insulin, except for the A21 position, where it has Gly instead of Asn. It has two additional amino acids, Arg (B31) and Arg (B32), located at the end of the B-chain.
For further information and support please go to the website of the issuing Pharmacopoeia.
Insulin Glargine, a peptide produced by recombinant DNA techniques is composed of two chains - the A-chain (21 amino acids) and the B-chain (32 amino acids), making up a total of 53 amino acids. Its primary structure is almost identical to that of Human Insulin, except for the A21 position, where it has Gly instead of Asn. It has two additional amino acids, Arg (B31) and Arg (B32), located at the end of the B-chain.
Application
Insulin glargine USP reference standard suitable for use in specified USP compendial tests and assays.
Also used to prepare standard, standard stock and system suitability solutions for assay by liquid chromatography in conjunction with a UV detector according to the given below monographs of United States Pharmacopeia (USP):
Also used to prepare standard, standard stock and system suitability solutions for assay by liquid chromatography in conjunction with a UV detector according to the given below monographs of United States Pharmacopeia (USP):
- Insulin Glargine Injection
- Insulin Glargine
- 〈121〉 Insulin Assays
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
This product is part of the USP Biologics program.
Sales restrictions may apply.
related product
Product No.
Description
Pricing
WGK
nwg
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
监管及禁止进口产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Insulin Glargine
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 46(5) (2022)
Insulin Assays
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4) (2020)
Insulin Glargine Injection
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 46(5) (2022)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service